Clinical Cancer Research Bridging the Lab and the Clinic in Cancer Medicine Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Soong, R.
Right arrow Articles by Tabiti, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Soong, R.
Right arrow Articles by Tabiti, K.
Clinical Cancer Research Vol. 7, 3423-3429, November 2001
© 2001 American Association for Cancer Research


Regular Articles

Quantitative Reverse Transcription-Polymerase Chain Reaction Detection of Cytokeratin 20 in Noncolorectal Lymph Nodes1

Richie Soong2, Kurt Beyser, Oliver Basten, Andreas Kalbe, Josef Rueschoff and Karim Tabiti

Roche Diagnostics GmbH, 82377 Penzberg [R. S., A. K., K. T.]; Klinikum Kassel, 34041 Kassel [K. B., J. R.]; and Klinikum Fulda, 36001 Fulda [O. B.], Germany

Purpose: Unexpected reverse transcription-PCR detection of cytokeratin 20 (CK20) in samples from healthy individuals and cancer types not expected to express CK20 has cast uncertainty on the role of CK20 as a specific marker of disseminated colorectal cells. We aimed to clarify the specificity of CK20 by examining its expression profile by real-time reverse transcription-PCR.

Experimental Design: A quantitative real-time PCR assay on the LightCycler instrument was developed and used to examine CK20 expression in tumors and lymph nodes from subjects with colorectal and breast carcinoma, head and neck and vulval squamous cell carcinoma, and melanoma. To select a method for reproducible quantification, four approaches were evaluated.

Results: The developed assay allowed rapid, convenient-to-use, specific, sensitive, and reproducible CK20 quantification amenable to large-scale analysis. For quantity calculation, an efficiency-adjusted relative ratio method was selected that controls for RNA loading and integrity as well as inefficient PCR reactions and provides a platform for standardization across laboratories. Using this assay, we detected CK20 in 41 of 89 (46%) lymph nodes from noncolorectal cancer types. There was a strong association between CK20 detection and lymph node metastasis determined by histology (P < 0.0001). Quantitatively, CK20 expression levels in colorectal cancer lymph nodes significantly exceeded the levels obtained in lymph nodes of extracolonic carcinomas (P < 0.05). Mean CK20 levels in lymph nodes and tumors from subjects with colorectal and breast cancers were similar in a tumor-type specific fashion.

Conclusions: These results characterize low-level, epithelial cell-specific CK20 expression in infiltrated lymph nodes from subjects with noncolorectal cancer types and demonstrate the potential advantages of detecting circulating epithelial cells by quantitative PCR.




This article has been cited by other articles:


Home page
Mol Hum ReprodHome page
S. Henriquez, A. Tapia, M. Quezada, M. Vargas, H. Cardenas, M. Rios, A.M. Salvatierra, H. Croxatto, P. Orihuela, F. Zegers-Hochschild, et al.
Deficient expression of monoamine oxidase A in the endometrium is associated with implantation failure in women participating as recipients in oocyte donation
Mol. Hum. Reprod., December 1, 2006; 12(12): 749 - 754.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
N. Dandachi, M. Balic, S. Stanzer, M. Halm, M. Resel, T. A. Hinterleitner, H. Samonigg, and T. Bauernhofer
Critical Evaluation of Real-Time Reverse Transcriptase-Polymerase Chain Reaction for the Quantitative Detection of Cytokeratin 20 mRNA in Colorectal Cancer Patients
J. Mol. Diagn., November 1, 2005; 7(5): 631 - 637.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
X. T. Wang, W. Sienel, S. Eggeling, C. Ludwig, E. Stoelben, J. Mueller, C. A. Klein, and B. Passlick
Detection of disseminated tumor cells in mediastinoscopic lymph node biopsies and lymphadenectomy specimens of patients with NSCLC by quantitative RT-PCR
Eur. J. Cardiothorac. Surg., July 1, 2005; 28(1): 26 - 32.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
R. Soong and A. Ladanyi
Improved Indicators for Assessing the Reliability of Detection and Quantification by Kinetic PCR
Clin. Chem., June 1, 2003; 49(6): 973 - 976.
[Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. Marutsuka, S. Shimada, K. Shiomori, N. Hayashi, Y. Yagi, T. Yamane, and M. Ogawa
Mechanisms of Peritoneal Metastasis after Operation for Non-Serosa-invasive Gastric Carcinoma: An Ultrarapid Detection System for Intraperitoneal Free Cancer Cells and a Prophylactic Strategy for Peritoneal Metastasis
Clin. Cancer Res., February 1, 2003; 9(2): 678 - 685.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.